More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 105.60 +10.25 (10.75%)
Prev. Close $95.35  
Open$93.96 
52 Wk High$ 
52 Wk Low$ 
Day High$105.72 
Day Low$91.01 
P/E N/A  
EPS$ 
Volume1,025,187 

Friends, Peers and Foes (?): TOI, ALNY, ARGX, BBIO, BIIB (more...)

Jul 13, 2026 05:00 PM Form 4 Dianthus Therapeutics, For: Jul 09 Filed by: Savitz Ryan
Jul 9, 2026 04:27 PM Form 144 Dianthus Therapeutics, Filed by: Savitz Ryan
Jul 2, 2026 04:01 PM Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
Jun 29, 2026 07:01 AM Dianthus starts Phase 3 trial of claseprubart in myasthenia gravis
Jun 29, 2026 07:00 AM Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Jun 18, 2026 04:30 PM Form 4 Dianthus Therapeutics, For: Jun 17 Filed by: Veness Adam M
Jun 17, 2026 04:33 PM Form 144 Dianthus Therapeutics, Filed by: Veness Adam M
Jun 12, 2026 02:53 PM Raymond James on Dianthus Therapeutics (DNTH) Amid 8% Gain: 'Incrementally More Bullish On The CIDP Program (again)'
Jun 12, 2026 07:01 AM Form 8-K Dianthus Therapeutics, For: Jun 12
Jun 10, 2026 04:10 PM Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
View All Articles

Entities mentioned with DNTH

View All Entities